| Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 3855 | 2018 |
| High prevalence of mutantKRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients K Allenson, J Castillo, FA San Lucas, G Scelo, DU Kim, V Bernard, ... Annals of Oncology 28 (4), 741-747, 2017 | 449 | 2017 |
| Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes R Gao, S Bai, YC Henderson, Y Lin, A Schalck, Y Yan, T Kumar, M Hu, ... Nature biotechnology 39 (5), 599-608, 2021 | 362 | 2021 |
| Pre-existing functional heterogeneity of tumorigenic compartment as the origin of chemoresistance in pancreatic tumors S Seth, CY Li, IL Ho, D Corti, S Loponte, L Sapio, E Del Poggetto, EY Yen, ... Cell reports 26 (6), 1518-1532. e9, 2019 | 87 | 2019 |
| Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer EH Lips, T Kumar, A Megalios, LL Visser, M Sheinman, A Fortunato, ... Nature genetics 54 (6), 850-860, 2022 | 44 | 2022 |
| A spatially resolved single-cell genomic atlas of the adult human breast T Kumar, K Nee, R Wei, S He, QH Nguyen, S Bai, K Blake, M Pein, ... Nature 620 (7972), 181-191, 2023 | 36 | 2023 |
| SCMarker: ab initio marker selection for single cell transcriptome profiling F Wang, S Liang, T Kumar, N Navin, K Chen PLoS computational biology 15 (10), e1007445, 2019 | 32 | 2019 |
| Single-cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer A Schalck, D Sakellariou-Thompson, MA Forget, E Sei, TG Hughes, ... Cancer discovery 12 (10), 2330-2349, 2022 | 28 | 2022 |
| Archival single-cell genomics reveals persistent subclones during DCIS progression K Wang, T Kumar, J Wang, DC Minussi, E Sei, J Li, TM Tran, ... Cell 186 (18), 3968-3982. e15, 2023 | 11 | 2023 |
| Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk MM Almekinders, T Bismeijer, T Kumar, F Yang, B Thijssen, ... British journal of cancer 127 (7), 1201-1213, 2022 | 8 | 2022 |
| Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ EH Lips, T Kumar, A Megalios, LL Visser, M Sheinman, A Fortunato, ... medRxiv, 2021.03. 22.21253209, 2021 | 8 | 2021 |
| Abstract P4-07-04: Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS V Shah, A Megalios, R Shami, M Sridharan, CS de Souza, T Kumar, ... Cancer Research 80 (4_Supplement), P4-07-04-P4-07-04, 2020 | 5 | 2020 |
| Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a … T Kumar, E Hobbs, F Yang, JT Chang, A Contreras, ERP Cuentas, ... Clinical Cancer Research 28 (17), 3669-3676, 2022 | 3 | 2022 |
| Tumor immune microenvironment (TiME) changes by multiplex IF staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a BRCA mutation. E Hobbs, F Yang, T Kumar, A Contreras, ER Parra Cuentas, H Garber, ... Journal of Clinical Oncology 37 (15_suppl), 585-585, 2019 | 1 | 2019 |
| Decoding the archetypes and eco-hubs of triple-negative breast cancer in responses to chemotherapy Y Yan, Y Lin, T Kumar, S Bai, J Li, T Tran, M Hu, E Ravenberg, M Rauch, ... Cancer Research 84 (6_Supplement), 6933-6933, 2024 | | 2024 |
| Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample PM Cinciripini, DW Wetter, J Wang, R Yu, G Kypriotakis, T Kumar, ... Scientific reports 14 (1), 6385, 2024 | | 2024 |
| Decoding the natural biology of triple-negative breast cancer and response to chemotherapy by single-cell transcriptomics T Kumar, Y Lin, Y Yan, S Bai, J Li, T Tran, M Hu, E Ravenberg, M Rauch, ... Cancer Research 83 (7_Supplement), 2147-2147, 2023 | | 2023 |
| Archival single cell sequencing reveals persistent subclones over years to decades of DCIS progression K Wang, T Kumar, J wang, D Minussi, E Sei, J li, T Tran, A Thennavan, ... Cancer Research 83 (7_Supplement), 125-125, 2023 | | 2023 |
| Abstract PR002: Genomic predictor can discriminate between high-and low-risk DCIS MR Escorza, M Sheinman, T Bismeijer, AA Ahmed, V Shah, JR Marks, ... Cancer Prevention Research 15 (12_Supplement_1), PR002-PR002, 2022 | | 2022 |
| Simultaneous TCR and transcriptomic sequencing of single Tcells defines biological subtypes in pancreatic cancer for adoptive Tcell therapy A Schalck, D Sakellariou-Thompson, MA Forget, E Sei, T Hughes, S Bai, ... Cancer Research 82 (12_Supplement), 2847-2847, 2022 | | 2022 |
Nicholas NavinMD Anderson Cancer CenterVerified email at mdanderson.org
